96 results
Page 5 of 5
20-F
7yj e6c8h50ae40
25 Feb 19
Annual report (foreign)
5:08pm
6-K
EX-99.1
e9wgdioe q7
25 Feb 19
Gamida Cell Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
4:15pm
6-K
EX-99.1
n6ueb7 bepbayvki
21 Feb 19
Current report (foreign)
2:06pm
6-K
EX-99.1
m43ofj
19 Feb 19
Gamida Cell Announces Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells
2:05pm
DRS
fzhrpz9wxwgzxx
15 Feb 19
Draft registration statement
12:00am
6-K
EX-99.1
0ljq5rjgxu
25 Jan 19
Gamida Cell Announces Data from NAM-NK and NiCord® Programs to Be Presented at 2019 TCT Annual Meeting
12:22pm
6-K
EX-99.1
nqd5bnxxoshg1yk9m
7 Jan 19
Gamida Cell Announces 2019 Goals and Provides Company Update
4:25pm
S-8
EX-99.2
t8m4bi3
9 Nov 18
Registration of securities for employees
2:24pm
424B4
ph9tm9we0h2yg6tr9p
30 Oct 18
Prospectus supplement with pricing info
8:35am
F-1/A
ba8 hx90m58kpdb
17 Oct 18
Registration statement (foreign) (amended)
6:06am
F-1/A
EX-10.6
ujujs5pseizwj
17 Oct 18
Registration statement (foreign) (amended)
6:06am
F-1
EX-3.1
soa3qkfe
28 Sep 18
Registration statement (foreign)
4:29pm
F-1
EX-10.6
ef7xqspab g4hy
28 Sep 18
Registration statement (foreign)
4:29pm
F-1
pd5mik 2sj11repbxm32
28 Sep 18
Registration statement (foreign)
4:29pm
DRS/A
8di jo49x
3 Jul 18
Draft registration statement (amended)
12:00am
DRS
l4i 9zr46idz1udggwe1
1 Jun 18
Draft registration statement
12:00am